AAAAAA
Results:
1-9
|
Results: 9
Authors:
Calvet, X
Garcia, N
Gene, E
Campo, R
Brullet, E
Sanfeliu, I
Citation: X. Calvet et al., Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment, ALIM PHARM, 15(7), 2001, pp. 1061-1065
Authors:
Calvet, X
Gene, E
Lopez, T
Gisbert, JP
Citation: X. Calvet et al., What is the optimal length of proton pump inhibitor-based triple therapiesfor H-pylori? A cost-effectiveness analysis, ALIM PHARM, 15(7), 2001, pp. 1067-1076
Authors:
Calvet, X
Gene, E
Sanfeliu, I
Citation: X. Calvet et al., Therapeutic strategies in Helicobacter pylori infection, MED CLIN, 116(6), 2001, pp. 239-239
Authors:
Calvet, X
Bustamante, E
Montserrat, A
Roque, M
Campo, R
Gene, E
Brullet, E
Citation: X. Calvet et al., Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test, EUR J GASTR, 12(8), 2000, pp. 949-953
Authors:
Garcia, N
Calvet, X
Gene, E
Campo, R
Brullet, E
Citation: N. Garcia et al., Limited usefulness of a seven-day twice-a-day quadruple therapy, EUR J GASTR, 12(12), 2000, pp. 1315-1318
Authors:
Calvet, X
Garcia, N
Lopez, T
Gisbert, JP
Gene, E
Roque, M
Citation: X. Calvet et al., A meta-analysis of short versus long therapy with a proton pump inhibitor,clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection, ALIM PHARM, 14(5), 2000, pp. 603-609
Authors:
Gene, E
Calvet, X
Azagra, R
Citation: E. Gene et al., Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers - a cost-effectiveness analysis, ALIM PHARM, 14(4), 2000, pp. 433-442
Authors:
Gene, E
McCall, J
Citation: E. Gene et J. Mccall, Management of hepatocellular carcinoma in New Zealand, NZ MED J, 113(1109), 2000, pp. 172-175
Authors:
Calvet, X
Carod, C
Gene, E
Citation: X. Calvet et al., Re: Peppers at treatment for Helicobacter pylori infection, AM J GASTRO, 95(3), 2000, pp. 820-821
Risultati:
1-9
|